Raising the Bar in the Care of Patients with Crohn’s Disease: Evidence-Based Strategies for Improved Outcomes

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. How many patients with Crohn’s disease do you manage per week? 

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. Please select the option that best describes your practice setting.

Academic medical center

Community hospital or medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with Crohn’s disease in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Be better able to manage patients with IBD through use of tools to monitor disease activity

Be better able to utilize evidence-based strategies to formulate optimal treatment regimens

Other (please explain)

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply. 

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please explain)

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD	Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD Strongly agree	Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD Agree	Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD Neutral	Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD Disagree	Target objective measures of disease activity to prevent disease progression, bowel damage, and disability in patients with IBD Strongly disagree
Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD	Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD Strongly agree	Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD Agree	Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD Neutral	Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD Disagree	Utilize clinical trial, evidence-based guidelines, and comparative effectiveness research on approved treatments to appropriately position therapy for patients with CD Strongly disagree

Question Title

* 10. Aline Charabaty, MD, AGAF, FACG, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 11. Edward V. Loftus, Jr., MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 12. Sultan Mahmood, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 13. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 14. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for Crohn’s disease:

Raising the Bar in the Care of Patients with Crohn’s Disease: Evidence-Based Strategies for Improved Outcomes – Journal Club Evaluation (i800-4)

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with Crohn’s disease do you manage per week?

Question Title

* 3. Please select the option that best describes your practice setting.

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with Crohn’s disease in your practice?

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating

After participating in today’s activity, I am now better able to:

Question Title

* 10. Aline Charabaty, MD, AGAF, FACG, effectively:

Question Title

* 11. Edward V. Loftus, Jr., MD, effectively:

Question Title

* 12. Sultan Mahmood, MD, effectively:

Question Title

* 13. The content presented:

Question Title

* 14. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for Crohn’s disease:

Question Title

* 16. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with Crohn’s disease do you manage per week?

Question Title

* 3. Please select the option that best describes your practice setting.

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with Crohn’s disease in your practice?

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 9. Please rate your level of agreement by checking the appropriate ratingAfter participating in today’s activity, I am now better able to:

Question Title

* 10. Aline Charabaty, MD, AGAF, FACG, effectively:

Question Title

* 11. Edward V. Loftus, Jr., MD, effectively:

Question Title

* 12. Sultan Mahmood, MD, effectively:

Question Title

* 13. The content presented:

Question Title

* 14. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for Crohn’s disease:

Question Title

* 16. If you indicated that you perceived commercial bias or influence, please describe:

* 2. How many patients with Crohn’s disease do you manage per week? 

* 8. What barriers do you see to making changes in your practice? Please select all that apply. 

* 9. Please rate your level of agreement by checking the appropriate rating

After participating in today’s activity, I am now better able to: